Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions
Open Access
- 22 September 2014
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 168 (3), 443-451
- https://doi.org/10.1111/bjh.13130
Abstract
Red blood cell (RBC) antibodies can persist for decades or decrease quickly to undetectable levels. Antibody persistence has not been systematically studied. Women whose children are treated with intrauterine transfusions (IUT) for haemolytic disease of the fetus (HDFN) often produce additional antibodies, which can be evoked by the intrauterine transfusion or by fetomaternal haemorrhage during the procedure. Factors associated with persistence of both the antibodies responsible for HDFN and additional antibodies were studied in 260 women whose children were treated with IUT between 1988 and 2008. They possessed 499 (205 anti‐D and 294 non‐D) antibodies after the last IUT. After a median follow‐up of 8·7 years, all 260 antibodies primarily responsible for HDFN had persisted. Additional antibodies directed against antigens of the children persisted in 70·6%, and in 32·3% if they were not child‐specific (P < 0·001). Antibodies induced by irradiated IUT persisted in only 7·1%. Multivariate analyses showed that non‐HDFN antibody persistence was dependent on the antibody titre and specificity. In conclusion, persistence of antibodies mainly depends on antibody strength and specificity. Difference between fetal or non‐fetal immunogens suggests maintenance of antigenic stimulation possibly by long‐term fetomaternal chimerism.Funding Information
- Fetal Maternal Research Foundation Leiden (n.a.)
- Sanquin Blood Supply (PPOC07-029)
This publication has 32 references indexed in Scilit:
- Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in InfancyClinical and Vaccine Immunology, 2013
- The establishment of the plasma cell survival niche in the bone marrowImmunological Reviews, 2012
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensThe New England Journal of Medicine, 2007
- High‐level long‐term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injuryTransfusion, 2005
- Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunizationAmerican Journal of Obstetrics and Gynecology, 2005
- Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999Acta Obstetricia et Gynecologica Scandinavica, 2004
- Microchimerism: incidental byproduct of pregnancy or active participant in human health?Trends in Molecular Medicine, 2002
- Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonismThe Journal of Pediatrics, 1997
- Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Long Persistence of Rhesus AntibodiesVox Sanguinis, 1966